Trademark applications and grants for Allgenesis Biotherapeutics Inc. Allgenesis Biotherapeutics Inc has 2 trademark applications. The latest application filed is for "ALLGENESIS"
Patent Application | Date |
---|---|
OPHTHALMIC FORMULATIONS OF TYROSINE KINASE INHIBITORS, METHODS OF USE THEREOF, AND PREPARATION METHODS THEREOF 20220280506 - 17/750400 NGUYEN; Tan ;   et al. | 2022-09-08 |
FUSION PROTEINS FOR INHIBITING ANGIOGENESIS 20200181214 - 16/803561 WU; Pei-tzu ;   et al. | 2020-06-11 |
CRYSTALLINE FORMS OF 3-Z-[1-(4-(N-((4-METHYL-PIPERAZIN-1-YL)-METHYLCARBONYL)-N-METHYL-AMINO)-P- HENYLAMINO)-1-PHENYL-METHYLENE]- 20200002294 - 16/570710 LIU; Fei ;   et al. | 2020-01-02 |
FUSION PROTEINS FOR INHIBITING ANGIOGENESIS 20190194271 - 16/282786 WU; Pei-Tzu ;   et al. | 2019-06-27 |
OPHTHALMIC FORMULATIONS OF TYROSINE KINASE INHIBITORS, METHODS OF USE THEREOF, AND PREPARATION METHODS THEREOF 20180243294 - 15/964235 NGUYEN; Tan ;   et al. | 2018-08-30 |
Mark Image Registration | Serial | Trademark Application Date |
---|---|
![]() "ALLGENESIS" 5707152 87741560 |
ALLGENESIS 2018-01-03 |
![]() "ALLGENESIS BIOTHERAPEUTICS" 4953911 86569569 |
ALLGENESIS BIOTHERAPEUTICS 2015-03-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.